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Introduction
Quality control mechanisms in eukaryotic cells involve mole  cular 
chaperone-dependent protein folding and ubiquitin/protea  some-
dependent degradation. In addition, environmental stress such 
as heat shock or endoplasmic reticulum stress leads to a general 
down-regulation of translation (Wickner et al., 1999; Schneider, 
2000; Frydman, 2001; Harding et al., 2002).
Hsp90 is a molecular chaperone that functions in associa-
tion with many cochaperones to fold transcription factors, pro-
tein kinases, and many other clients (Millson et al., 2005; Zhao 
et al., 2005). Protein kinase folding is collaborative between 
Hsp90 and the molecular chaperone Cdc37. Cdc37 functions by 
stabilizing protein kinases or maintaining them in a folding-
competent conformation (Kimura et al., 1997). In addition, 
Cdc37 promotes the assembly of Hsp90–protein kinase com-
plexes (Stepanova et al., 1997), and expression of a dominant-
negative form that lacks the Hsp90-binding domain inhibits 
kinase activation in animal cells (Grammatikakis et al., 1999). 
Interestingly, similar truncations promote yeast cell viability, 
suggesting that complex formation between Hsp90 and Cdc37 
is not essential for their function in protein kinase maturation in 
all cases (Lee et al., 2002; Turnbull et al., 2005). Both chape-
rones interact directly with kinases during folding, and inhibi-
tion of Hsp90 with geldanamycin or other ansamycin antibiotics 
results in the rapid proteasome-dependent degradation of client 
kinases and transcription factors (MacLean and Picard, 2003; 
Pearl, 2005; Whitesell and Lindquist, 2005).
Protein kinase folding requires the action of several cha-
perones and cochaperones in addition to Cdc37 and˙Hsp90. 
Like nuclear receptors, initial chaperone interactions with un-
folded kinases requires Hsp70/40 chaperones that appear to pre-
pare the kinase for interaction with Cdc37 (Arlander et al., 
2006). Cdc37 needs to be phosphorylated at Ser13 (mammals) 
or Ser14/17 (yeast) by casein kinase II to interact with its kinase 
clients (Bandhakavi et al., 2003; Shao et al., 2003; Miyata and 
Nishida, 2004). Hsp90 is subsequently recruited into this com-
plex in a manner that is stimulated by the action of Sti1/Hop 
(Lee et al., 2004; Arlander et al., 2006). A stable ternary com-
plex between Hsp90, Cdc37, and the client kinase then forms. 
Interestingly, Cdc37 exists in dimeric form in solution but in 
monomeric form in this ternary complex (Vaughan et al., 2006). 
How the folding reaction proceeds from this point is unknown.
Although it is clear that Cdc37 is vital for the biogenesis of 
protein kinases, it remains unknown what proportion of the kinome 
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requires this and other chaperones for maturation. The binding 
site for Cdc37 on client protein kinases has been localized to the 
N lobe of the catalytic domain (Prince and Matts, 2004; Zhao 
et al., 2004) via highly conserved sequence motifs that stabilize 
nucleotide binding. These fi  ndings suggest a very general role 
for Cdc37 in kinome biogenesis because the sequences that 
  mediate chaperone interactions are present in virtually all kinases.
Previous studies have noted that Cdc37 is up-regulated 
in cancer cells and can act as an oncogene (Stepanova et al., 
2000a,b). As such, it may play an important role in regulating 
the signaling capacity of the cell, especially if it has a broad 
function across the kinome. To clarify the extent to which Cdc37 
controls protein kinase biogenesis, we fi  rst adopted a proteomic 
approach to understand how many different kinases are affected 
by the loss of Cdc37 function. By analyzing a large proportion of 
the yeast kinome, we observed that Cdc37 has a general function 
in maintaining the levels of most but not all kinases. In addition, 
we characterize a novel function for Cdc37 in protecting nascent 
kinase chains against rapid degradation by the proteasome.
Results
Cdc37 has a general role 
in kinome biogenesis
To establish what proportion of the yeast kinome is dependent 
on Cdc37 function, we performed a large-scale analysis of 
Figure 1. Effect  of  CDC37 mutation on protein kinase levels. (A) Schematic of the CDC37 locus showing the position where URA3 was inserted as well 
as the serine 14 to alanine mutation (S14A) in CDC37. Arrows denote the direction of transcription. (B) Four examples of unstable kinases identiﬁ  ed with 
anti-TAP (cells grown at 30°C). Western blots of the same samples with anti-Pgk1 are shown as loading controls. (C) Four examples of kinases that were 
  unchanged after culturing wild type and cdc37
S14A at 30°C. (D) Phylogenetic analysis of protein kinases used in this study. Kinases that accumulated to 
wild-type levels in the cdc37
S14A mutant are shown in red. Kinases in black accumulated at less than twofold compared with wild-type levels.CDC37 AND KINOME BIOGENESIS • MANDAL ET AL. 321
  kinase steady-state levels in wild-type and cdc37 mutant yeast. 
This analysis used the tandem affi  nity-purifi  ed (TAP)–tagged 
yeast library, in which each strain contains a different TAP- 
tagged gene (Ghaemmaghami et al., 2003). The TAP tag was 
used as a means of identifying individual kinases after the 
  replacement of wild-type CDC37 with a mutant version known 
to affect kinase maturation (Bandhakavi et al., 2003). This muta-
tion, serine 14 to alanine (cdc37
S14A), precludes phosphorylation 
at amino acid 14 by casein kinase II. A second phosphorylation 
site at serine 17 was left intact. Selection of the mutant was 
made possible by insertion of an auxotrophic marker (URA3) in 
the intergenic region between cdc37
S14A and the downstream 
gene STB3 (Fig. 1 A). Ura
+ transformants were rescreened for 
a temperature-sensitive lethal growth phenotype at 37°C, which 
was diagnostic for replacement of the wild-type gene with the 
cdc37
S14A mutant (Dey et al., 1996; Bandhakavi et al., 2003).
A large-scale analysis was performed using TAP-tagged 
kinases isolated from the library. 65 strains containing different 
TAP-tagged kinases ( 50% of the kinome) were converted to 
cdc37
S14A, and the steady-state levels of each were determined 
by Western blotting in comparison with the levels found in 
wild-type strains. Kinase identity was verifi  ed by size (predicted 
size of the protein plus the 21-kD tag) and by PCR analysis of 
the kinase-encoding gene from individual strains. Steady-state 
levels of each kinase were assessed by Western blotting in at 
least two independent transformants. Phosphoglycerate kinase 
was used as a loading control. Some kinases were not readily 
observed by direct Western blot analysis of crude extracts as 
a result of low abundance, and these were instead assayed after 
a single round of pull down with IgG–Sepharose beads (see 
  Materials and methods).
Of the 65 kinases assayed, 51 displayed reduced steady-
state levels by at least twofold in the cdc37
S14A mutant strain 
compared with the wild type. 14 kinases accumulated to the 
same levels in both wild-type and cdc37
S14A strains (less than a 
twofold difference; n > 4) when the cells were grown at 30°C. 
Examples of the primary data are shown in Fig. 1 (B and C), and 
the combined dataset is presented in Fig. 1 D as a phylogenetic 
tree. Multiple sequence alignment revealed no strong evolutio-
nary relationships that distinguish those kinases affected by 
  mutation in CDC37 from those that were not. However, three 
kinases that were unaffected by the cdc37 mutant, Bud32, 
Ygl059W, and Yil042C, represent outliers based on their phylo-
genetic distance from others in the group. All three have atypi-
cal structure: Bud32 utilizes Mn
2+ instead of Mg
2+ (Facchin 
et al., 2002), and Ygl059W and Yil042C are similar to mito-
chondrial branched-chain α-ketoacid dehydrogenase kinases. 
The overwhelming majority of the other kinases analyzed 
have broad distributions in cytosolic or nuclear compartments 
(55 kinases). Three are localized to vesicle intermediates in the 
secretory pathway (Akl1, Ire1, and Vps15), and four have 
  ambiguous distributions (Mkk1, Ydl025c, Sat4, and Iks1; Huh 
et al., 2003).
The binding of Cdc37 is restricted to the N domain of pro-
tein kinases, which comprises fi  ve β sheets that pack against a 
single conserved α helix (the αC helix). This structure is also found 
in lipid kinases (Hanks and Hunter, 1995; Walker et al., 1999). 
Therefore, we tested whether any lipid kinases required Cdc37 
for stability. Strains expressing TAP-tagged Pik1 (PI4 kinase) 
and Vps34 (a PI3 kinase) strains were converted to cdc37
S14A, 
and their steady-state levels were assayed by Western blotting 
(Fig. 2). Both had reduced accumulation in the cdc37
S14A mutant 
compared with the wild-type strain. Two other kinases that 
phosphorylate metabolic intermediates, Guk1 (a guanylate kinase) 
and Prs5 (a subunit of ribose phosphate diphosphokinase), accu-
mulated to wild-type levels in the cdc37
S14A mutant strain. These 
combined data indicate that most protein kinases have access to 
and require Cdc37 for biogenesis at normal growth  temperatures, 
whereas a smaller proportion of kinases accumulate to wild-
type levels independent of Cdc37.
Protein kinases can function in pathways that have a self-
regulatory capacity to control their own cellular abundance. In 
the pheromone-responsive pathway, kinase components such 
as Ste11, Ste7, and Fus3 are under transcriptional control that 
  depends on a basal level of pathway activation (Fields et al., 1988; 
Hagen et al., 1991). Deletion of any of these kinases leads to 
  reduced basal signal transmission, resulting in decreased levels of 
other proteins within the pathway. Therefore, it is possible that 
the reduced kinase levels we observed in the cdc37
S14A mutant 
could result from the inhibition of just a single kinase within the 
pathway, and this leads to further indirect decreases in the levels 
of other kinases. This is illustrated in Fig. 3, in which deletion 
of the known chaperone client STE11 (Abbas-Terki et al., 2000) 
resulted in decreased levels of Fus3, a mitogen-activated protein 
kinase that is downstream in the pheromone-responsive pathway. 
However, the mutation of CDC37 results in a further reduction 
in Fus3 levels. Similar results were observed when BCK1 was 
deleted and the levels of Slt2 protein kinase (which is down-
stream in the PKC signaling pathway) were measured. The 
 deletion  of  BCK1 resulted in reduced levels of Slt2, and these 
were further reduced in the bck1∆/cdc37
S14A double mutant 
(Fig. 3 B). These results show that kinase expression can be 
 affected indirectly by the activity of other kinases but that Cdc37 
has additional functions to control kinase abundance.
The results shown in Fig. 3 demonstrate that protein 
  kinases affect the levels of other kinases within a pathway. 
Figure 2.  Analysis of lipid kinases in a cdc37
S14A strain. (A) Western blot 
analysis of TAP-tagged Pik1 (arrow) and Pgk1 in wild-type (ser14) and 
  cdc37
S14A (ala14) strains. (B) Analysis of Vps34; details are as described in A. 
(C and D) Analysis of Guk1 and Prs5 steady-state levels by Western blotting. 
In each case, the arrow indicates the position of the TAP-tagged protein.JCB • VOLUME 176 • NUMBER 3 • 2007  322
In the case of pheromone-responsive and PKC-dependent path-
ways, this regulation is at a transcriptional level (Fields et al., 1988; 
Hagen et al., 1991; Jung and Levin, 1999). Accordingly, if 
Cdc37 affects protein kinase abundance via the indirect method, 
this should result in changes in kinase gene mRNA levels. 
To test this hypothesis, we performed a microarray analysis 
to determine whether the cdc37
S14A mutation affects kinase 
gene expression on a general level. However, a comparison of 
  transcriptomes between wild-type and cdc37
S14A mutant strains 
showed no statistically signifi  cant changes in kinase gene ex-
pression when the cells were grown at 30°C. This was confi  rmed 
by quantitative PCR analysis of several kinases whose protein 
levels were reduced in the cdc37
S14A mutant (unpublished data). 
In contrast, statistically signifi  cant changes (P < 0.05) in ex-
pression were observed for a small number of genes, with the 
maximal fold change being less than twofold. The top three 
genes with higher expression in the mutant strain (YLR168C, 
RSM22, and ODC2) all function in mitochondria.
Cdc37 protects nascent chains 
from rapid degradation
We next investigated the fate of kinases that accumulated at 
  reduced levels in the cdc37
S14A mutant, focusing fi  rst on Tpk2. 
Pulse-chase analysis showed that Tpk2 levels were reduced by 
at least twofold in the cdc37
S14A mutant immediately after a 
10-min pulse compared with the wild type (Fig. 4 A). Once syn-
thesized, the levels of Tpk2 altered little in either strain over a 
2-h period. Pulse labeling of Pho85 and Rim11 resulted in simi-
larly decreased kinase levels in the cdc37
S14A mutant (Fig. 4, 
E and F). Experiments with Cmk2, whose accumulation at steady 
state was normal in the cdc37
S14A mutant, showed that it also 
  accumulated normally under pulse-labeling conditions (Fig. 4 B).
The decrease in Tpk2, Pho85, and Rim11 levels under 
pulse-labeling conditions could represent the rapid degradation 
of each kinase or a defect in translation. Degradation by the 
vacuolar pathway was ruled out by experiments in a pep4∆ mu-
tant and incubation of cells with PMSF. Incubation of cells with 
PMSF or deletion of the gene encoding the vacuolar peptidase 
Pep4 did not lead to substantial increases in the levels of Tpk2 
or Rim11 in cdc37 mutant cells (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200604106/DC1). Translation 
was assessed by examination of polysome profi  les and by quan-
titation of the levels of kinase mRNA on the polysomes from 
wild-type and cdc37 mutant cells. However, polysome profi  les 
from wild-type and cdc37
S14A strains were identical, suggesting 
that general defects in translation initiation and elongation do 
not occur in the cdc37
S14A mutant (Fig. S2). Furthermore, the 
cdc37
S14A strain did not display growth hypersensitivity on me-
dia containing paromomycin (Fig. S2), which is common for 
mutants that affect translation, such as ssb1∆/ssb2∆ (Nelson 
et al., 1992). Quantitative analysis of kinase mRNA levels in 
polysomes and 80S ribosomes also failed to reveal any dif-
ferences between the wild-type and cdc37
S14A mutant strains.
Further studies addressed whether kinase levels were re-
duced in the cdc37
S14A mutant as a result of rapid degradation by 
the proteasome. MG132 was incubated with cells for 30 min 
before the pulse labeling. Under these conditions, we observed 
that Tpk2 levels were increased in the cdc37
S14A mutant strain 
compared with DMSO alone and that the kinase appeared as 
two closely migrating bands (Fig. 4 C). Levels of Tpk2 in wild-
type cells were unaffected by the presence of MG132, suggest-
ing that the kinase is not subject to degradation during translation 
under normal conditions. However, these results strongly sup-
port the notion that Cdc37 protects nascent chains from degra-
dation either during or immediately after translation. Importantly, 
this type of quality control is mechanistically distinct from that 
which occurs upon Hsp90 inhibition with geldanamycin. Under 
conditions in which geldanamycin is incubated with cells for 
30 min before pulse labeling, there is no difference in the amount 
of Tpk2 synthesized after the pulse, yet there is a profound sub-
sequent reduction in kinase levels after 2 h of chase (Fig. 4 D). 
Similar results were observed for Slt2 and Kss1 kinases (unpub-
lished data).
The effect of MG132 on the levels of several other kinases 
during pulse labeling was also examined. Pho85, a cyclin-
  dependent kinase, behaved in a similar manner to Tpk2. The 
  kinase was present in reduced amounts in the cdc37
S14A mutant 
compared with the wild type after a 5-min pulse, and MG132 
partially suppressed this defect (Fig. 4 E). Rim11 levels were 
also reduced in the cdc37
S14A mutant, and, in this case, MG132 
led to the accumulation of a slower migrating band that is pre-
sent in all samples but is typically present as a minor component 
of the immunoprecipitation (Fig. 4 F). This band may represent 
a nonphosphorylated form of Rim11. Similar pulse-labeling 
studies were performed with Cdc28, the cyclin-dependent 
  kinase that promotes cell cycle progression. Surprisingly, levels 
Figure 3.  Regulation of kinase levels by 
other kinases and Cdc37. (A) Schematic of the 
  pheromone-responsive mitogen-activated protein 
kinase pathway is shown at the left. Levels 
of Fus3 in wild-type (WT) cells (lane 1), ste11∆ 
cells (lane 2), and ste11∆/cdc37
S14A cells 
(lane 3) are shown at the right. (B) Schematic 
at left shows the PKC signaling pathway. Levels 
of the Slt2 mitogen-activated protein kinase in 
wild-type cells (lane 1), bck1∆ cells (lane 2), 
and bck1∆/cdc37
S14A cells (lane 3) are shown 
at the right. (A and B) Pgk1 levels are shown 
as a loading control. Vertical lines denote 
  nonconsecutive lanes from the same gel and 
Western blots.CDC37 AND KINOME BIOGENESIS • MANDAL ET AL. 323
of Cdc28 were similar in both wild-type and cdc37
S14A strains 
after pulse labeling (Fig. 4 G) even though we observed greatly 
reduced levels of the kinase in the cdc37
S14A strain at steady 
state (Fig. 1 and not depicted). This paradox was resolved by 
pulse-chase analysis (Fig. 4 G), which shows that Cdc28 is syn-
thesized in the same amount in both wild-type and mutant 
strains, yet its levels decrease sharply in the cdc37
S14A strain 
within a 30-min period. As with Rim11, nascent Ccd28 ex-
pressed in the mutant cells migrates more slowly in the gel com-
pared with Cdc28 from wild-type cells, as noted previously 
(Gerber et al., 1995). These fi  ndings are consistent with previ-
ous studies on Cdc28 biogenesis in a different cdc37 mutant 
strain (Gerber et al., 1995; Farrell and Morgan, 2000) but con-
trast with the more rapid degradation observed for Tpk2, Pho85, 
and Rim11 (Fig. 4, C–E). This could refl  ect differences in chap-
erone binding between kinases that will be discussed later.
Cdc37 promotes kinase maturation
Protein folding is a temperature-dependent process, and chaper-
one dependence for folding is more stringent at higher growth 
temperatures. We investigated the temperature dependence of 
kinase accumulation in the cdc37
S14A mutant. Three protein 
  kinases that accumulated at low levels in the cdc37
S14A mutant 
were chosen for analysis (Rim11, Tpk2, and Yck2) based on 
their representation of different subgroups of the kinome 
(Hunter and Plowman, 1997). Notably, the kinases displayed 
similar stability profi   les that were inversely correlated with 
  increasing temperature (Fig. 5 A). Furthermore, each of the 
  kinases accumulated to levels that were similar to those found 
in the wild-type strain after growth at 26°C (Fig. 5 B). Next, we 
measured the activity of Tpk2 and Rim11 after growth of the 
cells at 26°C. The TAP-tagged kinases were assayed for activity 
after isolation on IgG–Sepharose beads from wild-type and 
  mutant strain lysates. A synthetic peptide substrate was used for 
Tpk2, and myelin basic protein (MBP) was used for Rim11 
(Zhu et al., 2000). The results of these assays (Fig. 5 C) showed 
that Rim11 and Tpk2 both had reduced activity when iso-
lated from the cdc37
S14A mutant strain compared with wild-type 
yeast even though similar amounts of kinase were present in 
the assays.
A further study addressed whether Tpk2, a cAMP-dependent 
protein kinase, could interact with its negative regulatory sub-
unit Bcy1 in the cdc37
S14A mutant strain (Toda et al., 1987). 
As with mammalian PKA, inhibitory binding of the regulatory 
subunit is relieved at high cAMP levels, leading to increased 
  kinase activity (Johnson et al., 1987). An HA-tagged version of 
Bcy1 was expressed in wild-type and cdc37
S14A mutant strains 
grown at 26 and 30°C. Similar amounts of HA-Bcy1 were ex-
pressed in both wild-type and cdc37
S14A mutant strains grown at 
both temperatures. TAP-tagged Tpk2 was isolated using IgG–
Sepharose bead resin, and the amount of coprecipitating Bcy1 
was detected by Western blotting. When the cells were grown at 
30°C, there was a decreased yield of TAP-Tpk2 by threefold 
(Fig. 5 D) as expected because of the decreased kinase levels 
(Fig. 4). The amount of coprecipitating Bcy1 was decreased by 
fi  vefold relative to those amounts isolated from the wild-type 
strain extracts. When the cells were grown at 26°C, however, 
similar amounts of TAP-Tpk2 were isolated, but twofold reduced 
levels of Bcy1 were still bound. This suggests that some popula-
tion of Tpk2 failed to bind to Bcy1 in the cdc37
S14A mutant, yet 
this correlated with the decreased activity of the kinase.
To determine whether Cdc37 was required for the activity 
of kinases that were synthesized normally at 30°C, we investi-
gated Sky1, a constitutively active kinase (Nolen et al., 2001). 
Sky1 has an extra helix between the αC helix and β4 sheet that 
helps stabilize the kinase. Because the αC/β4 loop is implicated 
in Cdc37 binding and for mediating kinase sensitivity to gel-
danamycin (Tikhomirov and Carpenter, 2003; Xu et al., 2005), 
we hypothesized that Sky1 folding might be chaperone inde-
pendent. However, Sky1 isolated from the cdc37
S14A mutant 
grown at 30°C was  50% less active than Sky1 isolated from 
the wild-type strain (Fig. 6), indicating that this kinase also re-
quires Cdc37 for effi  cient activation. When assayed after growth 
at 26°C, however, Sky1 had a similar activity when isolated 
Figure 4.  Pulse-chase analysis of kinases in the cdc37
S14A mutant. (A) 
Pulse-chase analysis of TAP-tagged Tpk2 in wild-type (WT) and cdc37
S14A 
mutant (S14A) cells. Chase times are indicated in minutes. (B) Pulse-chase 
analysis of TAP-tagged Cmk2 in wild-type and cdc37
S14A mutant (S14A) 
cells. (C) Pulse labeling of Tpk2 in wild-type cells and cdc37
S14A mutant 
(S14A) cells in the absence (lanes 1 and 3) or presence (lanes 2 and 4) 
of 100 μM MG132 added 30 min before pulse labeling (5-min pulse). 
(D) Pulse-chase experiment of Tpk2 in the presence of 50 μM geldanamycin 
(+GA) or DMSO (−GA) added 1 h before labeling. (C and D) Vertical 
lines denote nonconsecutive lanes from the same gel. (E) Pulse labeling and 
immunoprecipitation of Pho85 in wild-type (lanes 1 and 2) and cdc37
S14A 
mutant (S14A) cells in the absence (lanes 1 and 3) or presence of 100 μM 
MG132 (lanes 2 and 4) added 30 min before labeling. (F) As in E except 
that Rim11 kinase was immunoprecipitated. (G) Pulse-chase analysis of un-
tagged Cdc28 immunoprecipitated with anti-PSTAIRE in wild-type (lanes 
1–7) and cdc37
S14A mutant (S14A; lanes 7–12) cells. The band labeled 
with an asterisk is nonspeciﬁ  c. Chase times are given in minutes. The strain 
background for the experiments shown in C–G is erg6∆, which improves 
MG132 permeability (Lee and Goldberg, 1996; Lee et al., 1996).JCB • VOLUME 176 • NUMBER 3 • 2007  324
from either strain, suggesting that it became independent of 
Cdc37 at the lower growth temperature. Overall, kinases that 
are stable at 26 or 30°C in the cdc37
S14A mutant are less active 
than those in wild-type strains. Similar fi  ndings were made with 
the kinase Mps1, which is stably expressed in a cdc37 mutant 
but has decreased activity (Schutz et al., 1997). However, the 
chaperone dependence for kinase activity is inversely propor-
tional to growth temperature.
Discussion
There is accumulating evidence that Cdc37 has a general role in 
kinase biogenesis, but there has been no systematic analysis at 
a kinomic level. In our studies, we addressed this issue by anal-
ysis of  50% of the yeast kinome for dependence on Cdc37. 
Our results are consistent with Cdc37 having a general role in 
kinome biogenesis and functioning either during or immedi-
ately after translation to protect nascent chains from degrada-
tion. In addition, Cdc37 promotes kinase maturation to the 
folded state.
The fi  nding that Cdc37 plays a general role in kinase 
  biogenesis is consistent with the growing number of kinases 
that have been characterized to interact with this chaperone 
  (MacLean and Picard, 2003). Two other large-scale screens for 
Hsp90-interacting proteins also uncovered protein kinases. In a 
two-hybrid screen with a mutant form of Hsp90 as bait (Millson 
et al., 2005), six kinases were identifi  ed as interacting with 
Hsp90, and, in a multiapproach study (Zhao et al., 2005), 
27   kinases interacted with Hsp90 either physically or genetically. 
Interestingly, the kinases found in these studies did not overlap, 
indicating that neither screen was saturating.
The results of our studies show that Cdc37 functions im-
mediately after translation to protect nascent kinase chains from 
degradation. Even after a subminute pulse labeling, we noted 
that kinase levels were reduced in the cdc37
S14A mutant strain 
(unpublished data). However, proteasome inhibition followed 
by pulse labeling largely restored Tpk2, Pho85, and Rim11 
  levels, providing strong support for Cdc37’s role in nascent 
chain quality control. This phenotype was only observed when 
MG132 was incubated for brief periods (30 min) in the cells be-
fore pulse labeling. Prolonged treatments (2 h) failed to restore 
Tpk2 levels, although this may result from reduced transcrip-
tion occurring from long-term proteasome inhibition (unpub-
lished data).
The fi  nding that some kinases require Cdc37 to protect 
them against rapid degradation shortly after synthesis suggests 
that the chaperone functions as a conformational sensor at or 
near to the polysome. The degradation of several kinases during 
pulse labeling is so fast that we initially considered that trans-
lation itself was impaired. However, polysome profi  les  and 
measurement of the rate of protein synthesis suggested that 
Cdc37 was not involved in regulating translation, at least in a 
general manner (Fig. S2). Also, there is a precedent for the very 
rapid degradation of ribosomal proteins shortly after synthesis 
Figure 5.  Effect of temperature on kinase accumulation and activity. (A) Western blot analysis of Rim11, Tpk2, and Yck2 (arrows) after growth of the rele-
vant TAP-tagged cdc37
S14A strains at the indicated temperatures. Asterisks denote Pgk1, which was used as a loading control. (B) Comparison of Rim11 
(lanes 1 and 2), Tpk2 (lanes 3 and 4), and Yck2 (lanes 5 and 6) levels by Western blotting in whole cell extracts from wild-type (ser14) and cdc37
S14A 
(ala14) cells grown at 26°C. The asterisk denotes Pgk1. (C) Activity of protein kinases in the cdc37 mutant strain. Activity of Rim11 and Tpk2 after growth 
of the relevant TAP-tagged wild-type (WT) and cdc37
S14A cells at 26°C. The blots above the graph show Western blot analysis of protein levels of the kinases 
used in the assays. Error bars represent SEM. (D) Binding of HA-Bcy1 to Tpk2 in wild-type (ser14; lanes 1 and 3) and cdc37
S14A (ala14; lanes 2 and 4) 
cells grown at 30 and 26°C as indicated. Top panels show Western blots of Tpk2; middle panels show HA-Bcy1 (Bcy1) after immunoprecipitation (IP) of 
TAP-Tpk2 using IgG–Sepharose beads; bottom panel shows levels of HA-Bcy1 in cell lysates. Note that two bands appear in the anti-HA Western blots, but 
only the slower migrating band coimmunoprecipitated with TAP-Tpk2 (not depicted).CDC37 AND KINOME BIOGENESIS • MANDAL ET AL. 325
(Warner et al., 1985; Maicas et al., 1988). Although it is unclear 
whether this quality control pathway is the same as the one 
  observed here, a recent study has discovered a role for Hsp90 in 
the biogenesis of some ribosomal proteins (Maicas et al., 1988; 
Kim et al., 2006).
Therefore, our results are consistent with the hypothesis 
that Cdc37 protects some nascent kinase chains from rapid deg-
radation immediately after translation. Whether Cdc37 binds 
directly to the nascent chain as it is being synthesized or binds 
immediately afterward may depend on where in the polypeptide 
chain the kinase domain is located. Scroggins et al. (2003) have 
observed Cdc37 binding to polysomes programmed with heme-
regulated inhibitor kinase, for example, but not with lymphocyte-
specifi  c protein tyrosine kinase. In our own studies, we failed 
to observe Cdc37 binding to polysomes isolated from yeast 
even when such polysomes were enriched for Ste11 kinase 
mRNA (unpublished data). What remains unclear is how such 
a function for Cdc37 is integrated with those of Hsp70/40 
  chaperones that interact with misfolded kinases before Cdc37 
binding, at least in vitro (Arlander et al., 2006). The function 
of Cdc37 in stabilizing kinase nascent chains suggests that it 
belongs to the newly defi  ned group of chaperones linked to 
  protein synthesis (Albanese et al., 2006). This group includes 
others that are known to promote protein kinase biogenesis such 
as Ydj1 and Sse1. However, Cdc37 appears to be distinct from this 
group in other ways because the cdc37 mutant did not display 
hypersensitivity to a translation inhibitor nor is CDC37 tran-
scriptionally coregulated with other components of the transla-
tional machinery. As pointed out by Albanese et al. (2006), 
however, some chaperones appear to function as both chape-
rones linked to protein synthesis and as stress-regulated chape-
rones that function in protein refolding, and this appears to 
apply to Cdc37.
Rapid degradation of nascent kinase chains in the cdc37 
mutant during pulse labeling was not observed in all cases. 
Cdc28 levels were similar in wild-type and cdc37 mutant strains 
after pulse labeling, but the kinase was degraded rapidly within 
a 30-min period. These fi  ndings are consistent with previous 
studies showing that Cdc37 promotes Cdc28 stability (Gerber 
et al., 1995; Farrell and Morgan, 2000). Whether Cdc28 represents 
a distinct class of kinase that is degraded by a different pathway 
is unclear. In our experiments, Cdc28 was untagged, contrasting 
with the C-terminal TAP-tagged kinases used in all other ex-
periments and providing a possible source for the phenotypic 
  distinction. However, it is also possible that Cdc28 is protected in 
its prefolded form by other chaperones and that loss of Cdc37 
function manifests at a slightly later stage in its maturation. This 
explanation for the delayed degradation of Cdc28 compared 
with Tpk2 or Rim11 may also account for why geldanamycin 
promotes degradation only after kinase synthesis. As shown in 
Fig. 4 D, Tpk2 is completely synthesized and stable for the 
  duration of a 5-min pulse even in the presence of geldanamycin, 
although it is rapidly degraded thereafter. These results are con-
sistent with the posttranslational role attributed to Hsp90 and 
with nascent kinases being stabilized by other chaperones, 
  including Cdc37 and Ydj1/Hsp70, before interacting with Hsp90 
for the fi  nal stages in maturation.
The temperature-sensitive phenotype for kinase stability 
in the cdc37
S14A mutant allowed us to further dissect the differ-
ent roles for this chaperone in kinase biogenesis. For Rim11 and 
Tpk2, the increase in kinase stability in cdc37
S14A when grown 
at 26°C did not lead to full activity; rather, a twofold decrease in 
activity was observed. For Tpk2, the decrease in activity of the 
isolated kinase correlated with decreased binding of its inhibi-
tory subunit Bcy1 in cell lysates. This could be caused by Tpk2 
misfolding and/or by increased cAMP levels in the cdc37
S14A 
cells caused by a combined decrease in Tpk1/2/3 activity 
  (Nikawa et al., 1987). These combined results are consistent 
with decreased kinase activity in cdc37
S14A mutant cells even 
when the triage system for degrading misfolded kinases is sup-
pressed by growth at low temperature.
A previous study supports the hypothesis that kinases can 
accumulate as misfolded conformers that are not degraded. In 
this case, the deletion of STI1 or HSC82 resulted in very low 
v-Src levels, an effect that was suppressed by the overexpression 
of full-length or truncated forms of Cdc37 (Lee et al., 2002). 
Although the full-length Cdc37 also restored v-Src activity, the 
truncated forms promoted stabilization without large increases 
in activity. Because v-Src is constitutively active in the absence 
of other kinases, these data indicate that v-Src accumulates in 
an improperly folded form that is not degraded. The same is 
likely true for Sky1, which is also constitutively active (Nolen 
et al., 2001). Furthermore, the accumulation of misfolded pro-
teins upon the deletion of several different chaperone proteins 
was recently demonstrated (McClellan et al., 2005). In this case, 
components of the Hsp90 chaperone machinery were impli-
cated in promoting degradation but not in the folding of a heter-
ologously expressed protein in yeast. For kinases, the triage 
system may operate to clear the cell of misfolded kinases close 
to their site of synthesis before they have a chance to aggregate. 
This can be bypassed by growth at low temperature even in the 
absence of chaperone function (Fig. 5 A). In this case, the effect 
of low temperature may compensate for decreased chaperone 
function and allow the kinases to proceed to a later stage of 
maturation with a greater probability of achieving the native state. 
We suspect this has physiological relevance because some kinases 
interact persistently with chaperones even after initial folding. 
Figure 6.  Sky1 dependence on Cdc37 is temperature dependent. Activity 
of Sky1 after the isolation of wild-type (ser14) and cdc37
S14A mutant 
(ala14) cells grown at 30 and 26°C as indicated. Bars represent SEM 
(n = 3).JCB • VOLUME 176 • NUMBER 3 • 2007  326
For these kinases, chaperones are constantly needed to 
promote the folded state rather than target the polypeptide 
for degradation.
In conclusion, our fi  ndings show that Cdc37 has a general 
role in protecting nascent kinase chains from degradation in addi-
tion to its function in posttranslational maturation. These fi  ndings 
suggest that Cdc37 is a gatekeeper to cellular kinase abundance. 
Importantly, yeast Cdc37 synthesis is fairly constant compared 
with other chaperones whose expression is stress regulated, and 
this may be a means of limiting kinase abundance in cells.
Materials and methods
Strains and plasmids
The TAP-tagged yeast library based on strain S288C was purchased from 
Open Biosystems. Strain genotype was veriﬁ  ed by sizing individual gene 
products by Western blotting and PCR analysis using one primer speciﬁ  c to 
the tag and one primer speciﬁ  c to the gene of interest.
The URA3-marked cdc37
S14A mutant (pS14AU) was constructed by 
inserting a 1.2-kb DNA fragment containing the URA3 gene into Bcl1-
  digested pRS314.cdc37S14A (a gift from C. Glover III, The University of 
Georgia, Athens, GA). A similar plasmid was constructed using wild-type 
CDC37 for microarray analysis. A plasmid encoding HA-tagged Bcy1 was 
a gift from J. Hirsch (Mount Sinai School of Medicine, New York, NY). 
A strain deleted for SSB1 and SSB2 was a gift from E. Craig (University 
of Wisconsin-Madison, Madison, WI).
The cdc37
S14A mutant strains were constructed as follows. Wild-type 
cells containing TAP-tagged kinases were grown overnight. A DNA frag-
ment containing cdc37
S14A::URA3 was prepared for transformation by 
  digesting pS14AU with BamH1, HindIII, and Kpn1. Transformation by the 
cdc37
S14A::URA3 fragment into the TAP-tagged strains was performed 
  using the standard lithium acetate method as previously described (Gietz 
et al., 1995) and transformants selected for growth in media lacking uracil. 
Ura
+ colonies were selected for further study based on having a temperature-
sensitive lethal growth phenotype at 37°C.
The yeast erg6∆ knockout strains were constructed as follows. The 
deletion allele (replaced by the KanMX4 module) was ampliﬁ  ed by PCR 
using primers that were 200 bp upstream of the start codon and 200 bp 
downstream of the stop codon. The resulting 2-kb products were used to re-
place the wild-type genes in the TAP-tagged strains under study by a modi-
ﬁ  ed version of the transformation protocol of Gietz et al. (1995), which 
included a heat-shock step at 42°C for 20 min followed by washing the 
cells with water, resuspension in YPD (yeast extract/peptone/glucose), 
and incubation at 30°C for 2 h before plating. Successful homologous 
  recombination was determined by selection on YPD media containing 
400 μg/ml G418 followed by reselection on complete synthetic dextrose 
media containing 200 μg/ml G418 minus histidine. Gene replacement 
was veriﬁ  ed by PCR analysis of the KanMX4 module in the proper location 
using one primer speciﬁ  c to the module (KanB; 5′-C  T  G  C  A  G  C  G  A  G  G  A  G  C-
C  G  T  A  A  T  -3′) and one 300 bp upstream from the start codon where the 
wild-type gene resided.
Western blot analysis
Western blot analysis was performed on whole cell extracts prepared in 
IPP150 (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% NP-40) plus 
Complete protease inhibitor (Boehringer) by glass bead lysis. An HRP-labeled 
rabbit Fc fragment followed by chemiluminescent detection was used in 
most experiments. In some experiments, anticalmodulin-binding peptide 
antibody was used (Open Biosystems). Some kinases were not detected in 
whole cell extracts but were readily detected after a single round of isola-
tion on IgG–Sepharose bead resin. Kinases in this class (a total of 16) were 
Rad53, Sgv1, Cdc7, Prr1, Ydl025c, Sat4, Ste11, Ynr047c, Hrk1, Npr1, 
Kin1, Ctk1, Ssk22, KKq8, Ipl1, and Ire1.
Pulse labeling and polysome proﬁ  le analysis
Pulse labeling, immunoprecipitations, and sucrose gradient analysis of poly-
some proﬁ  les were performed as described previously (Brodsky et al., 1998).
Kinase assays
Wild-type and cdc37
S14A cells expressing TAP-tagged forms of Rim11, 
Tpk2, and Sky1 were grown overnight (at 26°C for Rim11 and Tpk2 and 
at 30°C for Sky1) in 100 ml synthetic complete media (minus His and Ura) 
to log phase. Cells were harvested, and extracts were prepared using 
IPP150 (Seraphin et al., 2002). The cell extract concentrations were 
  adjusted to 0.45 ml at 3 mg/ml in IPP150 and were incubated with 50 μl 
of 50% vol/vol IgG–Sepharose bead resin (GE Healthcare) for 1 h at 4°C. 
The resin was washed four times using the same buffer and divided into 
two aliquots. One aliquot was used for Western blot analysis (see above), 
whereas the other was used for the kinase assay. Kinase assay for Tpk2 
was performed using the PepTag Nonradioactive Protein Kinase Assay kit 
(Promega) according to instructions provided by the manufacturer. Kinase 
activity was determined by absorbance at A570. Rim11’s and Sky1’s kinase 
activities were assayed by measuring their ability to phosphorylate MBP 
(Upstate Biotechnology). In addition to the aforementioned four washes, 
the resin was subsequently washed once with kinase buffer (10 mM Tris-
HCl, pH 7.5, and 10 mM MgCl2). The washed resin was incubated in 20 μl 
kinase buffer containing 1 μg MBP, 100 μM ATP, and 10 μCi [γ
32]ATP 
(PerkinElmer) for 20 min at room temperature. 20 μl of 2× SDS sample 
buffer (4°C) was added to stop the kinase reaction. The samples were 
  resolved by denaturing gel electrophoresis. The gel was ﬁ  xed and dried 
before autoradiography. Quantitation of MBP phosphorylation was deter-
mined using a phosphoimager (Storm 860; Molecular Dynamics) and 
  ImageQuant software (GE Healthcare).
Microarray analysis
Wild-type S288C yeast were converted to CDC37::URA3 or cdc37
S14A::
URA3 as described above. Cultures of each strain were grown to log 
phase, and total RNA was prepared as described previously (Schmitt et al., 
1990). A clean-up procedure was used with an RNeasy kit (QIAGEN) and 
on-column DNA digestion. Hybridization to S98 chips (Affymetrix, Inc.) 
and data analysis were performed by the Mount Sinai microarray facility.
Phylogenetic analysis
The analysis shown in Fig. 2 was performed on isolated kinase domains 
downloaded from http://kinase2.salk.edu. A multiple alignment was 
  performed with ClustalW in the MacVector software package (version 7; 
Accelrys) followed by phylogenetic analysis using Protdist and Neighbor 
present in the Phylip 3.6 package (http://evolution.genetics.washington
.edu/phylip.html). The tree was drawn using Hypertree (Bingham and 
Sudarsanam, 2000).
Online supplemental material
Fig. S1 shows that deletion of the vacuolar peptidase PEP4 or incubation 
of yeast cells with PMSF results in the accumulation of kinases Rim11 and 
Tpk2 but in a manner that is similar in wild-type and cdc37
S14A cells. These 
ﬁ  ndings rule out a role for the vacuole as a means of preferential kinase 
depletion in the cdc37
S14A mutant cells. Fig. S2 shows polysome proﬁ  les 
that are similar in wild-type and cdc37
S14A mutant cells. The sensitivity of 
yeast growth on paromomycin is also shown and demonstrates that 
cdc37
S14A mutant cells have a similar sensitivity to wild-type cells. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200604106/DC1.
We thank Drs. Elizabeth Craig, Claiborne Glover III, and Jeanne Hirsch for 
plasmids/yeast strains, Drs. Tearina Chu and Yuexun Liu for microarray analy-
sis, and John Woolford for use of his gradient fractionator. We also thank 
Drs. Doug Cyr, Stephen Garrett, Jeanne Hirsch, Bob Matts, Kevin Morano, and 
David Ron for helpful discussions during the course of this study. We are espe-
cially grateful to R. Deshaies for his insight regarding our work.
This study was supported by National Institutes of Health grants 
GM70596 (to A.J. Caplan) and GM 075061 (to J.L. Brodsky).
Submitted: 18 April 2006
Accepted: 26 December 2006
References
Abbas-Terki, T., O. Donze, and D. Picard. 2000. The molecular chaperone Cdc37 
is required for Ste11 function and pheromone-induced cell cycle arrest. 
FEBS Lett. 467:111–116.
Albanese, V., A.Y. Yam, J. Baughman, C. Parnot, and J. Frydman. 2006. Systems 
analyses reveal two chaperone networks with distinct functions in 
 eukaryotic  cells.  Cell. 124:75–88.
Arlander, S.J., S.J. Felts, J.M. Wagner, B. Stensgard, D.O. Toft, and L.M. Karnitz. 
2006. Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with 
 purifi  ed chaperones. J. Biol. Chem. 281:2989–2998.CDC37 AND KINOME BIOGENESIS • MANDAL ET AL. 327
Bandhakavi, S., R.O. McCann, D.E. Hanna, and C.V. Glover. 2003. A positive 
feedback loop between protein kinase CKII and Cdc37 promotes the 
  activity of multiple protein kinases. J. Biol. Chem. 278:2829–2836.
Bingham, J., and S. Sudarsanam. 2000. Visualizing large hierarchical clusters in 
hyperbolic space. Bioinformatics. 16:660–661.
Brodsky, J.L., J.G. Lawrence, and A.J. Caplan. 1998. Mutations in the cytosolic 
DnaJ homologue, YDJ1, delay and compromise the effi  cient translation 
of heterologous proteins in yeast. Biochemistry. 37:18045–18055.
Dey, B., J.J. Lightbody, and F. Boschelli. 1996. CDC37 is required for p60v-src 
activity in yeast. Mol. Biol. Cell. 7:1405–1417.
Facchin, S., R. Lopreiato, S. Stocchetto, G. Arrigoni, L. Cesaro, O. Marin, 
G. Carignani, and L.A. Pinna. 2002. Structure-function analysis of yeast 
piD261/Bud32, an atypical protein kinase essential for normal cell life. 
Biochem. J. 364:457–463.
Farrell, A., and D.O. Morgan. 2000. Cdc37 promotes the stability of protein 
  kinases Cdc28 and Cak1. Mol. Cell. Biol. 20:749–754.
Fields, S., D.T. Chaleff, and G.F. Sprague Jr. 1988. Yeast STE7, STE11, and 
STE12 genes are required for expression of cell-type-specifi  c genes. Mol. 
Cell. Biol. 8:551–556.
Frydman, J. 2001. Folding of newly translated proteins in vivo: the role of 
 molecular  chaperones.  Annu. Rev. Biochem. 70:603–647.
Gerber, M.R., A. Farrell, R.J. Deshaies, I. Herskowitz, and D.O. Morgan. 1995. 
Cdc37 is required for association of the protein kinase Cdc28 with G1 and 
mitotic cyclins. Proc. Natl. Acad. Sci. USA. 92:4651–4655.
Ghaemmaghami, S., W.K. Huh, K. Bower, R.W. Howson, A. Belle, N. Dephoure, 
E.K. O’Shea, and J.S. Weissman. 2003. Global analysis of protein expres-
sion in yeast. Nature. 425:737–741.
Gietz, R.D., R.H. Schiestl, A.R. Willems, and R.A. Woods. 1995. Studies on the 
transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. 
Yeast. 11:355–360.
Grammatikakis, N., J.H. Lin, A. Grammatikakis, P.N. Tsichlis, and B.H. Cochran. 
1999. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. 
Mol. Cell. Biol. 19:1661–1672.
Hagen, D.C., G. McCaffrey, and G.F. Sprague Jr. 1991. Pheromone response 
elements are necessary and suffi  cient for basal and pheromone-induced 
transcription of the FUS1 gene of Saccharomyces cerevisiae. Mol. Cell. 
Biol. 11:2952–2961.
Hanks, S.K., and T. Hunter. 1995. Protein kinases 6. The eukaryotic protein 
  kinase superfamily: kinase (catalytic) domain structure and classifi  cation. 
FASEB J. 9:576–596.
Harding, H.P., M. Calfon, F. Urano, I. Novoa, and D. Ron. 2002. Transcriptional 
and translational control in the mammalian unfolded protein response. 
Annu. Rev. Cell Dev. Biol. 18:575–599.
Huh, W.K., J.V. Falvo, L.C. Gerke, A.S. Carroll, R.W. Howson, J.S. Weissman, 
and E.K. O’Shea. 2003. Global analysis of protein localization in budding 
yeast. Nature. 425:686–691.
Hunter, T., and G.D. Plowman. 1997. The protein kinases of budding yeast: six 
score and more. Trends Biochem. Sci. 22:18–22.
Johnson, K.E., S. Cameron, T. Toda, M. Wigler, and M.J. Zoller. 1987. Expression 
in  Escherichia coli of BCY1, the regulatory subunit of cyclic AMP-
  dependent protein kinase from Saccharomyces cerevisiae. Purifi  cation 
and characterization. J. Biol. Chem. 262:8636–8642.
Jung, U.S., and D.E. Levin. 1999. Genome-wide analysis of gene expression reg-
ulated by the yeast cell wall integrity signalling pathway. Mol. Microbiol. 
34:1049–1057.
Kim, T.S., C.Y. Jang, H.D. Kim, J.Y. Lee, B.Y. Ahn, and J. Kim. 2006. Interaction 
of Hsp90 with ribosomal proteins protects from ubiquitination and 
 proteasome-dependent  degradation.  Mol. Biol. Cell. 17:824–833.
Kimura, Y., S.L. Rutherford, Y. Miyata, I. Yahara, B.C. Freeman, L. Yue, R.I. 
Morimoto, and S. Lindquist. 1997. Cdc37 is a molecular chaperone with 
specifi  c functions in signal transduction. Genes Dev. 11:1775–1785.
Lee, D.H., and A.L. Goldberg. 1996. Selective inhibitors of the proteasome-
 dependent and vacuolar pathways of protein degradation in Saccharomyces 
cerevisiae. J. Biol. Chem. 271:27280–27284.
Lee, D.H., M.Y. Sherman, and A.L. Goldberg. 1996. Involvement of the mo-
lecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-
lived and abnormal proteins in Saccharomyces cerevisiae. Mol. Cell. Biol. 
16:4773–4781.
Lee, P., J. Rao, A. Fliss, E. Yang, S. Garrett, and A.J. Caplan. 2002. The Cdc37 
protein kinase-binding domain is suffi  cient for protein kinase activity and 
cell viability. J. Cell Biol. 159:1051–1059.
Lee, P., A. Shabbir, C. Cardozo, and A.J. Caplan. 2004. Sti1 and Cdc37 can 
stabilize Hsp90 in chaperone complexes with a protein kinase. Mol. Biol. 
Cell. 15:1785–1792.
MacLean, M., and D. Picard. 2003. Cdc37 goes beyond Hsp90 and kinases. Cell 
Stress Chaperones. 8:114–119.
Maicas, E., F.G. Pluthero, and J.D. Friesen. 1988. The accumulation of three 
yeast ribosomal proteins under conditions of excess mRNA is determined 
primarily by fast protein decay. Mol. Cell. Biol. 8:169–175.
McClellan, A.J., M.D. Scott, and J. Frydman. 2005. Folding and quality control of 
the VHL tumor suppressor proceed through distinct chaperone pathways. 
Cell. 121:739–748.
Millson, S.H., A.W. Truman, V. King, C. Prodromou, L.H. Pearl, and P.W. Piper. 
2005. A two-hybrid screen of the yeast proteome for Hsp90 interactors 
uncovers a novel Hsp90 chaperone requirement in the activity of a stress-
activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryot. 
Cell. 4:849–860.
Miyata, Y., and E. Nishida. 2004. CK2 controls multiple protein kinases by phos-
phorylating a kinase-targeting molecular chaperone, Cdc37. Mol. Cell. 
Biol. 24:4065–4074.
Nelson, R.J., T. Ziegelhoffer, C. Nicolet, M. Werner-Washburne, and E.A. Craig. 
1992. The translation machinery and 70 kd heat shock protein cooperate 
in protein synthesis. Cell. 71:97–105.
Nikawa, J., S. Cameron, T. Toda, K.M. Ferguson, and M. Wigler. 1987. Rigorous 
feedback control of cAMP levels in Saccharomyces cerevisiae. Genes 
Dev. 1:931–937.
Nolen, B., C.Y. Yun, C.F. Wong, J.A. McCammon, X.D. Fu, and G. Ghosh. 
2001. The structure of Sky1p reveals a novel mechanism for constitutive 
 activity.  Nat. Struct. Biol. 8:176–183.
Pearl, L.H. 2005. Hsp90 and Cdc37–a chaperone cancer conspiracy. Curr. Opin. 
Genet. Dev. 15:55–61.
Prince, T., and R.L. Matts. 2004. Defi  nition of protein kinase sequence motifs 
that trigger high affi  nity binding of Hsp90 and Cdc37. J. Biol. Chem. 
279:39975–39981.
Schmitt, M.E., T.A. Brown, and B.L. Trumpower. 1990. A rapid and simple 
method for preparation of RNA from Saccharomyces cerevisiae. Nucleic 
Acids Res. 18:3091–3092.
Schneider, R.J. 2000. Translational control during heat shock. In Translational 
Control of Gene Expression. N. Sonenberg, J.W.B. Hershey, and M.B. 
Matthews, editors. Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, NY. 581–593.
Schutz, A.R., T.H. Giddings Jr., E. Steiner, and M. Winey. 1997. The yeast 
CDC37 gene interacts with MPS1 and is required for proper execution of 
spindle pole body duplication. J. Cell Biol. 136:969–982.
Scroggins, B.T., T. Prince, J. Shao, S. Uma, W. Huang, Y. Guo, B.G. Yun, K. 
Hedman, R.L. Matts, and S.D. Hartson. 2003. High affi  nity binding of 
Hsp90 is triggered by multiple discrete segments of its kinase clients. 
Biochemistry. 42:12550–12561.
Seraphin, B., O. Puig, E. Bouveret, B. Rutz, and F. Caspary. 2002. Tandem 
affi  nity  purifi   cation to enhance interacting protein identifi  cation.  In 
Protein-Protein Interactions: a Molecular Cloning Manual. E. Golemis, 
editor. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 
313–328.
Shao, J., T. Prince, S.D. Hartson, and R.L. Matts. 2003. Phosphorylation of ser-
ine 13 is required for the proper function of the Hsp90 co-chaperone, 
Cdc37. J. Biol. Chem. 278:38117–38120.
Stepanova, L., X. Leng, and J.W. Harper. 1997. Analysis of mammalian Cdc37, 
a protein kinase targeting subunit of heat shock protein 90. Methods 
Enzymol. 283:220–229.
Stepanova, L., M. Finegold, F. DeMayo, E.V. Schmidt, and J.W. Harper. 2000a. 
The oncoprotein kinase chaperone CDC37 functions as an oncogene in 
mice and collaborates with both c-myc and cyclin D1 in transformation 
of multiple tissues. Mol. Cell. Biol. 20:4462–4473.
Stepanova, L., G. Yang, F. DeMayo, T.M. Wheeler, M. Finegold, T.C. Thompson, 
and J.W. Harper. 2000b. Induction of human Cdc37 in prostate cancer 
correlates with the ability of targeted Cdc37 expression to promote pros-
tatic hyperplasia. Oncogene. 19:2186–2193.
Tikhomirov, O., and G. Carpenter. 2003. Identifi  cation of ErbB-2 kinase domain 
motifs required for geldanamycin-induced degradation. Cancer Res. 
63:39–43.
Toda, T., S. Cameron, P. Sass, M. Zoller, J.D. Scott, B. McMullen, M. Hurwitz, 
E.G. Krebs, and M. Wigler. 1987. Cloning and characterization of BCY1, 
a locus encoding a regulatory subunit of the cyclic AMP-dependent pro-
tein kinase in Saccharomyces cerevisiae. Mol. Cell. Biol. 7:1371–1377.
Turnbull, E.L., I.V. Martin, and P.A. Fantes. 2005. Cdc37 maintains cellular 
 viability  in  Schizosaccharomyces pombe independently of interactions 
with heat-shock protein 90. FEBS J. 272:4129–4140.
Vaughan, C.K., U. Gohlke, F. Sobott, V.M. Good, M.M. Ali, C. Prodromou, 
C.V. Robinson, H.R. Saibil, and L.H. Pearl. 2006. Structure of an Hsp90-
Cdc37-Cdk4 complex. Mol. Cell. 23:697–707.
Walker, E.H., O. Perisic, C. Ried, L. Stephens, and R.L. Williams. 1999. 
Structural insights into phosphoinositide 3-kinase catalysis and signalling. 
Nature. 402:313–320.JCB • VOLUME 176 • NUMBER 3 • 2007  328
Warner, J.R., G. Mitra, W.F. Schwindinger, M. Studeny, and H.M. Fried. 1985. 
Saccharomyces cerevisiae coordinates accumulation of yeast ribosomal 
proteins by modulating mRNA splicing, translational initiation, and pro-
tein turnover. Mol. Cell. Biol. 5:1512–1521.
Whitesell, L., and S.L. Lindquist. 2005. HSP90 and the chaperoning of cancer. 
Nat. Rev. Cancer. 5:761–772.
Wickner, S., M.R. Maurizi, and S. Gottesman. 1999. Posttranslational qual-
ity control: folding, refolding, and degrading proteins. Science. 
286:1888–1893.
Xu, W., X. Yuan, Z. Xiang, E. Mimnaugh, M. Marcu, and L. Neckers. 2005. 
Surface charge and hydrophobicity determine ErbB2 binding to the 
Hsp90 chaperone complex. Nat. Struct. Mol. Biol. 12:120–126.
Zhao, Q., F. Boschelli, A.J. Caplan, and K.T. Arndt. 2004. Identifi  cation of a 
conserved sequence motif that promotes Cdc37 and Cyclin D1 binding to 
Cdk4. J. Biol. Chem. 279:12560–12564.
Zhao, R., M. Davey, Y.C. Hsu, P. Kaplanek, A. Tong, A.B. Parsons, N. Krogan, 
G. Cagney, D. Mai, J. Greenblatt, et al. 2005. Navigating the chaperone 
network: an integrative map of physical and genetic interactions mediated 
by the hsp90 chaperone. Cell. 120:715–727.
Zhu, H., J.F. Klemic, S. Chang, P. Bertone, A. Casamayor, K.G. Klemic, 
D. Smith, M. Gerstein, M.A. Reed, and M. Snyder. 2000. Analysis of 
yeast protein kinases using protein chips. Nat. Genet. 26:283–289.